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SUMMARY
In this paper we describe the effect of depletion of splenic macrophages on the uptake, and
immune response against, different formulations of rabies virus antigen. Splenic macrophages
were removed by intravenous injection with clodronate liposomes. ,B-propiolacton inactivated
rabies virus (RV-BPL) and immune-stimulating complexes (iscom) containing these antigens were
given to macrophage-depleted and control mice. In the absence of phagocytic cells in the spleen,
antigen is still trapped in the red pulp and to a lesser extent in the peri-arteriolar lymphocyte
sheaths (PALS) for both antigen formulations. The localization pattern in the main area of
immune response induction, namely the follicles, was unaltered after macrophage depletion.
Functionally, the depletion of splenic and liver macrophages had no influence on the induction
of specific antibody responses in both RV-BPL or RV-iscom immunized mice, even though the
latter presentation form was clearly associated with specific localization in the marginal metallophil-
lic macrophages. In RV-BPL immunized mice, macrophage depletion had no influence on
proliferative T-cell responses. However, macrophage-depleted mice that were immunized with RV-
iscom showed a significant decrease in proliferative T-cell responses. These results confirm existing
ideas on the spleen as a physical filter rather than an induction site for humoral responses and
shed new light on the efficient role of iscoms as antigen-presenting moieties in relation to their
specific in vivo localization patterns and partial macrophage dependency.
INTRODUCTION
Several mechanisms have been postulated to explain the rela-
tively high immunogenicity of antigens presented in immune-
stimulating complexes (iscoms)."2 Their potency can in part
be explained by the specific targeting of these structures to
antigen-presenting cells (APC) of the immune system. Recently
we developed a novel method for the in situ detection of
iscoms.3 Employing this technique we demonstrated that
iscoms containing rabies virus antigen were taken up by a
different subset of macrophages in the spleen than inactivated
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rabies virus antigen, thereby possibly explaining the difference
in immunogenicity. Furthermore, we found a surprising prefer-
ence for iscom, rather than intact virus, in the follicular
trapping/uptake of these antigens. These results led to a
biphasic presentation model for iscom with a specific localiz-
ation pattern in marginal metallophilic macrophages (MMM),
away from antigen-degrading macrophages, in the first phase
and direct presentation to follicular cells in the second phase.
This model implies an entire or at least partial dependency of
the iscom-induced immune response on this particular macro-
phage subset. From several studies it has now become evident
that the spleen processes antigen in two possible ways,
depending on different types of non-lymphoid cells. Firstly,
there seems to be a macrophage-dependent pathway for
particulate-and thymus-independent type 1 fmitogenic poly-
saccharides) antigens.4 Second, there is an important role for
the follicular (dendritic and B) cells of the spleen in trapping
and presenting soluble protein and TI-2 antigens to the immune
system.5 Because both virus (RV-BPL) and iscom can qualify
as particulate antigens it remains to be established whether
these antigens also require macrophage (pre)-processing before
they can evoke an effective immune response. In view of our
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earlier study on the difference in splenic localization of these
two formulations of rabies antigen and based on the available
literature suggesting a suppressive rather that immune-
stimulating role of splenic macrophages we decided to study
the contribution of splenic macrophages in these responses.
By making use of a well-established technique for splenic
macrophage elimination, employing clodronate liposomes, the
role of macrophages, as opposed to the function of follicular
cells (which are not affected), can be determined.5 By making
use of the discrete differences in repopulation kinetics of
different splenic macrophage subsets6 their role in immune
response induction could be studied. Furthermore, this elimin-
ation model can be combined with the above mentioned
labelling technique, thereby enabling the study of in situ
antigen localization under macrophage-free conditions.
MATERIALS AND METHODS
Animals and chemicals
Female BALB/c mice aged 12-16 weeks, were kept in macrolon
cages under an 11 hr dark/13 hr light regimen at 200 and were
given acidified water (pH 3) and pelleted mouse food (Hope
Farms, Woerden, The Netherlands) ad libitum. DiI (1,1'-
dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate;
D-282) was obtained from Molecular Probes, Eugene, OR.
Clodronate liposomes were prepared as described earlier.7
Antigens
Rabies virus (RV-Pasteur strain) was propagated in Vero-cell
monolayer cultures.8 Culture supernatant was cleared by fil-
tration and concentrated by Amicon ultrafiltration (cutoff
106 MW). Virus was inactivated with 3-propiolacton (BPL)
and stored at -70° at a concentration of 900 jg/ml. This
rabies virus antigen was used for the preparation of RV-
iscoms, as described earlier.9 Briefly RV-proteins were solubil-
ized with 10% MEGA-10 (decanoyl-N-methylglucamide) for
2 hr. at room temperature. The solubilized virus was layered
on top of a 10% sucrose cushion and centrifuged for 2 hr at
200000g. Quil-A (Iscotec AB, Lulea', Sweden), cholesterol
and phosphatidylcholine (Sigma-Aldrich, Zwijndrecht, the
Netherlands) were added to the supernatant and the mixture
was dialysed overnight against phosphate-buffered saline
(PBS). Free Quil-A and unincorporated proteins were removed
by centrifugation over a 20% sucrose cushion for 48 hr at
150 000 g. Incorporation ofRV proteins was verified by sodium
dodecyl sulphate-polyacrylamide gel eletrophoresis (SDS-
PAGE) analysis and a glycoprotein specific enzyme-linked
immunosorbent assay (ELISA).'0
Immunological responses
Clodronate liposomes were prepared as described in detail
before,7 briefly: 75 mg phosphatidylcholine and 11 mg choles-
terol were dissolved in chloroform in a 500 ml round-bottomed
flask. The thin film that formed on the interior of the flask
after low vacuum rotary evaporation at 370 was dispersed by
gentle rotation for 15 min with 10 ml PBS (0-15 M NaCl/10 mi
phosphate buffer pH 7 4) containing 1 89 g dichloromethylene
diphosphonate (a kind gift of Boehringer Mannheim,
Germany). The milky white suspension was kept for 2 hr at
room temperature and sonicated for 3 min at 200 in a Sonicor
waterbath sonicator (50 Hz, Farmingdale, NY). After an
additional 2 hr at room temperature, the liposome suspension
was diluted to 100ml in PBS and centrifuged (100000g,
30 min) to remove free clodronate. Liposomes were resus-
pended in 4 ml PBS and microscopically checked for formation
and size homogeneity. Three animals per group were injected
i.v. with 200 [d Clodronate-liposomes or PBS intravenously.
48 hr after treatment animals were immunized with 1 jig RV-
iscom or with 10 jg RV-BPL. At day 40 animals were again
treated with either Clodronate liposomes or with PBS and
animals were booster immunized at day 42. At day 49 animals
were killed and the spleen was removed for T-cell proliferation
studies. Immunological responses were measured 1 week after
the last i.v. immunization at day 42. Rabies virus specific
antibody responses were measured by antigen binding ELISA
as described earlier. and T-cell responses were measured as
described earlier." Briefly, spleen cells were isolated and
stimulated with varying concentrations of RV-BPL. After 5
days cells were pulsed with [3H]thymidine for 18 hr. Cells were
harvested on glass filters and incorporated radioactivity was
measured in a Betaplate scintillation counter (LKB, Uppsala,
Sweden). Sera were taken at weekly intervals and were analysed
in a rabies-virus-specific ELISA for the induction of specific
antibodies.
Fluorochrome labelling ofrabies virus antigen and R V-iscoms
Stock solution of DiI and was made in pure ethanol
(2-5 mg/ml). 100 jig RV-BPL, RV-iscoms or empty iscoms
were mixed with 20 mg DiI in PBS and incubated for one
hour at 370. After labelling the samples were filtered using
0 45 mm filters to separate crystalline DiI and labelled anti-
gens. Labelled material was stored in the dark at 4° for up
to 4 weeks. Administration was performed i.v. for several
doses ranging from 0 1 to 10 jig per mouse.
Fluorescence microscopy
Frozen sections (8 gm) of organs under study were observed
and photographed directly after cryo-sectioning with an
Olympus (Tokyo) Vanox fluorescent microscope. DiI fluores-
cence was observed both as red with green light (excitation
filter BP 545) and 'rhodamine/TRITC' optics (emission: EO
570).
Enzyme cytochemistry
Organ sections used for localization studies based on fluores-
cence microscopy were air-dried and fixed in acetone for
enzyme staining. Endogenous acid phosphatase staining for
the identification of all splenic and liver phagocytes was
performed as described in detail earlier.'3
RESULTS
Localization of virus and iscom in the spleen after macrophage
depletion.
Already at 30 min after i.v. administration of DiI labeled RV-
BPL preferential uptake by marginal zone macrophages
(MZM) could be observed in control mice (PBS at -48 hr)
with some antigen also being taken up by red pulp macro-
phages. This image was identical to the localization patterns
we described in a recent study for normal untreated mice.3
The preferential uptake by MZM was maintained when
observing sections at 60 or 120 min (Fig. la) and proved
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Figure 1. In this figure the uptake of Dil-labelled antigens is shown in the spleen 2 hr after i.v. injection. (a) Uptake of RV-BPL
in normal untreated animals. (b) Uptake of RV-BPL in clodronate treated animals. (c) Uptake of RV-iscom in untreated animals.
(d) Uptake of RV-iscom in clodronate treated animals, R, red pulp, M, marginal zone, P, peri-arteriolar lymphocyte sheath.
completely in accordance with other localization studies on
particulate thymus dependent antigens.14"15
Splenic macrophages were depleted by i.v. administration
of clodronate liposomes,"6 depletion was complete as con-
firmed with enzyme histochemistry for acid phosphatase of
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alternating sections from those shown in Fig. 1 (data not
shown). Irrespective of this complete absence of macrophages
from the spleen, a massive trapping and retention of DiI-
labelled RV-BPL could be observed (irrespective of the dose
given). Contrary to the discrete localization pattern found in
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normal or PBS treated mice (in MZM and red pulp), RV-BPL
seemed to be evenly distributed over all splenic compartments
(Fig. lb).
As described before,' iscom was taken up preferentially by
MMM (bright yellow dots in Fig. lc) and to a lesser extent
by MZM and on cells in the follicles. In macrophage-depleted
animals iscom was trapped and retained almost exclusively in
the marginal zone and red pulp of the spleen (irrespective of
the dose given). Contrary to RV-BPL almost no iscom localiz-
ation could be observed in the PALS area of depleted animals
(Fig. Id).
Immunological responses after depletion of spleen macrophages
Based on dose-response curves generated before3 we chose for
similarity of eventual titre rather than dose of immunization
(antigen). In this scenario 1 jg of RV-iscom is equivalent to
10 jg of RV-BPL, both resulting in virus neutralising anti-
bodies, specific T cells and 100% survival after challenge (i.e.
full protection).3
Rabies-virus-specific antibody responses in serum were
measured weekly in antigen-specific ELISA. Serum samples
were analysed weekly after depletion of splenic macrophages
and subsequent immunization to observe possible effects
caused by macrophage repopulation of the spleen. It was
established that at day 7 no repopulation of the spleen with
macrophages has yet occured, marginal metallophils reappear
between 14 and 21 days and at day 28 the normal situation is
almost completely restored (4.6,17 and data not shown). As is
shown in Fig. 2(a) (represenative experiment from three per-
formed) no difference in the kinetics of the antibody response
could be observed when splenic macrophages were removed
in RV-iscom immunized animals as compared with untreated
animals. It should be noted that a trend towards higher titers
in depleted RV-BPL animals could be observed (not
significant).
The clodronate treatment was repeated at day 40 and
animals were booster immunized with RV-iscom at day 42.
Both treated and untreated animals showed increased serum
titres at 7 days after boost immunization as compared to
primary responses. Again, no effect of the clodronate liposome
treatment was observed. Identically, humoral responses after
immunization with RV-BPL were unaffected after clodronate
liposome treatment.
Proliferative splenocyte responses in RV-BPL immunized
animals were unaffected after treatment with clodronate lipo-
somes (Fig. 2c). However, when splenic macrophages were
removed prior to immunization with RV-iscom a significant
decrease in rabies-virus-specific spleen-cell responses could be
observed (Fig. 2d). In vitro restimulation of T cells with either
inactivated antigen or antigen as provided by paraformal-
dehyde (PFA)-fixed persistently ERA (Evelyn-Rokitnicky-
Abelseth)-infected P815 (H2d, haplotype) cells was also
significantly decreased in clodronate liposome-treated animals.
DISCUSSION
In this study we show that the T-cell mediated immune
response against rabies virus iscom is partly dependent on
splenic macrophages. Depletion of macrophages resulted in
almost identical in situ localization patterns for rabies virus
antigen presented as inactivated virus or in iscom. The elimin-
ation of splenic macrophages has no effect on the humoral
response against rabies virus for both antigen formulations.
When given in sufficiently high doses, 'empty' liposomes
can efficiently block and suppress the macrophage system.18'19
Similarly, macrophages can be suppressed or depleted by using
substances such as carrageenan, silica, carbonyl iron or anti-
bodies.20 We have developed and applied a liposome-suicide
technique for the actual elimination of macrophages.""6 The
resulting modulation studies have firmly established the role
of macrophages in innate (antigen removal) rather than in
adaptive (antigen presentation) immunity.45"'5 Emphasizing
the role of what is now called professional antigen presenting
cells, such as dendritic and B cells, in the generation of
antibodies and cellular immunity.5 Not very surprising it could
be established in a similar fashion that the macrophage is the
principal antigen-presenting cell for liposome-encapsulated
antigens2' as well as for other particulate antigens.'5'22
Furthermore, CTL responses induced by membranous vesicles
but not those induced by syngeneic antigen pulsed splenocytes
proved to be macrophage dependent23. Iscom and inactivated
virus can be regarded as hydrophobic particulate antigens. In
this study no differences in humoral response were observed
in macrophage-depleted cells as compared with untreated
animals, at the antigen dose and immunization regime studied.
In view of the finding that trapping of both antigens occurs
on follicular cells in depleted animals it can be concluded that
follicular dendritic or follicular B cells are involved in antigen
presentation of both RV-BPL and iscom. This observation, in
combination with the observed decrease in T-cell responses
against iscom in depleted animals, suggests a role for both
follicular cells and MMM in the presentation of iscom. And
no or very limited role for MMM in the presentation of
RV-BPL.
To induce an efficient MHC class I restricted immune
response, involving the production of antigen specific cyto-
toxic T-cells (CTL), it seems necessary to target the antigen
to the cytoplasm29 or induce processing by dedicated macro-
phages2224. It was shown that both anionic and cationic32
pH-sensitive liposomes could enter the class-I restricted
(endoplasmatic reticulum/Golgi) pathway.22,24,25 The
addition of Quil A to liposomes has been shown to efficiently
enhance their capacity to induce CD8+ CTL.26 Quil-A is an
adjuvant and toxic by itself, and a crucial component of
iscom which belong to the most potent adjuvants, for
hydrophobic proteins, known.'3 Both rabies virus iscom and
RV-BPL can induce antigen-specific, class-I restricted CTL.
Quil A containing liposomes proved to be an effective vehicle
to shuttle hydrophillic proteins into the major histocompat-
ibility complex (MHC) class I pathway, resulting in induction
of CD8 + cytotoxic T lymphocytes (CTL). These and other4'27
data point to a conflicting role for macrophages in direct
stimulation of T cells in some systems and suppression of T
cells in others.
We have shown previously that the T-cell responses are
not directly influenced by treatment with clodronate lipo-
somes.28 Consequently the observed decrease in T-cell prolifer-
ation in RV-iscom immunized animals is likely a result from
the absence of splenic macrophages. Because no decrease was
observed in the CD4 T-cell dependent humoral response the
observed decrease can be explained by in the class-1 restricted
© 1998 Blackwell Science Ltd, Immunology, 94, 455-460
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Figure 2. In this figure the rabies virus specific immunological responses are shown before and after treatment with clodronate
liposomes. Rabies virus specific ELISA serum titres in RV-BPL (a) and RV-iscom (b) immunized animals immunization.
Proliferative spleen cell responses in RV-BPL (c) and RV-iscom (d) immunized animals.
CTL response which is dependent on the presence of macro-
phages. Such a decrease has been described for the generation
ofprimary ovalbumin (OVA)-specific CTL after splenic macro-
phage elimination.29 Why this decrease does not occur in
RV-BPL immunized animals, which normally generate CTL
activity as well, remains unclear but, in combination with the
localization data, it suggests a role for the MMM subset in
the (pre)processing of antigen in iscom and not in other
unactivated antigen forms.
Removal of splenic and hepatic macrophages with clodron-
ate liposomes is very efficient and actually eliminates phago-
cytic cells from the tissues altogether.'6 As described before in
studies using radioactively labelled liposomes"0 this removal
does not result in persistently increased serum levels of the
antigen nor in a decrease of splenic uptake or a change of
antigen localization patterns. The present results show the
localization patterns of this nonphagocytic trapping by the
spleen. As observed for a soluble thymus-independent antigen'
it is evident that antigen is still trapped by follicular (dendritic
or B) cells of the spleen after macrophage depletion. In view
of the crucial role of dendritic cells29 and follicular dendritic
cells in the presentation of antigens to the immune system3'5
this is an important observation. Furthermore, this is in
accordance with the primary function of the spleen, namely
as a filter of the blood.4'5 In a large number of studies it has
now been shown that removal of marginal zone macrophages
leads to a relative increase of humoral immune responses
against particulate antigens17 or antigens in oil emulsions.3'
This trend is also visible in this study (Fig. 2b). The preferential
localization of iscom in MMM certainly leads to relative
protection of the antigen for the degradable action of marginal
zone macrophages and provides an explanation for the relative
effectiveness (10-25-fold efficiency gain in terms of dose3) of
iscom in inducing immune responses. Studies involving devel-
opment or optimization of iscom or other antigen presenting
moieties should therefore include similar in vivo localization
and modulation studies to better predict eventual efficacy. This
in turn will lead to vaccines with higher efficacy at much lower
antigen concentrations because much less antigen is lost by
immunologically non-specific filtering.
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